Biodesix Inc (BDSX)

Currency in USD
13.140
-0.170(-1.28%)
Closed·
13.400+0.260(+1.98%)
·
BDSX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.00013.800
52 wk Range
3.43620.210
Key Statistics
Prev. Close
13.31
Open
13.02
Day's Range
13-13.8
52 wk Range
3.436-20.21
Volume
30.5K
Average Volume (3m)
158.26K
1-Year Change
19.6721%
Book Value / Share
-0.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BDSX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.000
Upside
+128.31%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Biodesix Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Biodesix Inc Earnings Call Summary for Q4/2025

  • Q4 2025 revenue surged 41% YoY to $28.8M, driven by 46% growth in lung diagnostics segment to $25.1M
  • Company achieved first-ever positive Adjusted EBITDA of $530K; net loss improved 52% to $4.0M in Q4 2025
  • Gross margins expanded 400 basis points to 83% in Q4; expects to maintain near 80% margins throughout 2026
  • Stock jumped 9.98% in aftermarket to $12.93 following results; Q4 2026 revenue forecast at $29.8M
  • Strategic partnerships with Thermo Fisher and Bio-Rad, plus expanded sales force, driving continued growth momentum
Last Updated: 2026-02-26, 05:22 p/m
Read Full Transcript

Compare BDSX to Peers and Sector

Metrics to compare
BDSX
Peers
Sector
Relationship
P/E Ratio
−3.8x9.7x−0.5x
PEG Ratio
−0.13−0.300.00
Price/Book
−53.9x2.9x2.6x
Price / LTM Sales
1.5x4.1x3.3x
Upside (Analyst Target)
128.3%36.5%43.8%
Fair Value Upside
Unlock11.5%5.3%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.000
(+128.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy20.00+52.21%-MaintainMar 02, 2026
William Blair
Buy---UpgradeFeb 27, 2026
Canaccord Genuity
Buy20.00+52.21%-MaintainJan 13, 2026
Canaccord Genuity
Buy20.00+52.21%-MaintainNov 04, 2025
Canaccord Genuity
Buy20.00+52.21%30.00MaintainSep 19, 2025

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
-0.49 / -0.04
Revenue / Forecast
28.76M / 24.54M
EPS Revisions
Last 90 days

BDSX Income Statement

People Also Watch

5.8100
OWLT
+6.02%
3.06
BATL
-14.29%
55.97
ITRN
+1.91%
1.180
VCIG
+4.42%

FAQ

What Is the Biodesix (BDSX) Stock Price Today?

The Biodesix stock price today is 13.140 USD.

What Stock Exchange Does Biodesix Trade On?

Biodesix is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Biodesix?

The stock symbol for Biodesix is "BDSX."

What Is the Biodesix Market Cap?

As of today, Biodesix market cap is 132.810M USD.

What Is Biodesix's Earnings Per Share (TTM)?

The Biodesix EPS (TTM) is -4.670.

When Is the Next Biodesix Earnings Date?

Biodesix will release its next earnings report on Nov 03, 2025.

From a Technical Analysis Perspective, Is BDSX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Biodesix Stock Split?

Biodesix has split 1 times.

How Many Employees Does Biodesix Have?

Biodesix has 334 employees.

What is the current trading status of Biodesix (BDSX)?

As of Apr 20, 2026, Biodesix (BDSX) is trading at a price of 13.140 USD, with a previous close of 13.310 USD. The stock has fluctuated within a day range of 13.000 USD to 13.800 USD, while its 52-week range spans from 3.436 USD to 20.210 USD.

What Is Biodesix (BDSX) Price Target According to Analysts?

The average 12-month price target for Biodesix is 30.000 USD, with a high estimate of 40 USD and a low estimate of 20 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +128.31% Upside potential.

What Is the BDSX Premarket Price?

BDSX's last pre-market stock price is 13.060 USD. The pre-market share volume is 140.000, and the stock has decreased by -0.250, or -1.880%.

What Is the BDSX After Hours Price?

BDSX's last after hours stock price is 13.400 USD, the stock has decreased by 0.260, or 1.980%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.